Alpha-1 Antitrypsin Deficiency clinical trials at UC Davis
1 research study open to eligible people
Showing trials for
Long-term, Open-label Study of SAR447537 (INBRX-101) in Adults With Alpha-1 Antitrypsin Deficiency Emphysema
“Alpha 1 Antitrypsin Deficiency Infusion Trial”
open to eligible people ages 18-80
Phase 2 open label extension study to evaluate SAR447537 (INBRX-101) in adults with AATD emphysema
Sacramento, California and other locations
Last updated: